In line, Ariza and colleagues found in a cohort of more than 700 patients with cirrhosis that urine LCN2 was markedly increased in the patients when compared to healthy control samples, establishing urine LCN2 as a prognostic marker of cirrhosis (Ariza et al., 2016). This evidence concerns the gene LCN2 and Cirrhosis.